Updated:
OJ Medtech
OJ Medtech family office in Bay Shore, NY: invests in MedTech, healthcare services, and life sciences.
OJ Medtech
OJ Medtech was established as a single-family office in Bay Shore, New York, with a stated focus on investments in the medical technology and healthcare services sectors. The firm's founding principals are not publicly identified, but the office's name and location suggest ties to the MedTech industry, possibly originating from the sale or operation of medical device companies (per public record). The investment strategy at OJ Medtech centers on direct investments and co-investments in early- to growth-stage MedTech companies, including medical devices, diagnostics, and digital health platforms. Known portfolio exposures include orthopedic devices, surgical robotics, and remote monitoring technologies, though specific companies are not disclosed. The office targets North American markets, with potential expansion into European healthcare innovation hubs. Total capital under management is not disclosed, and the size of the team is unknown. OJ Medtech operates leanly, likely with fewer than 10 professionals managing investments directly. It may maintain philanthropic structures separate from the investment entity, but these are not publicly named. The firm's structural differentiator lies in its niche specialization within MedTech, providing patient capital and operational expertise to healthcare startups. This focus contrasts with broader family offices that invest across multiple sectors, allowing OJ Medtech to offer deep industry knowledge and long-term support to portfolio companies.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Bay Shore
Corporate office
Bay Shore, NY, United States
Sector focus
Frequently asked questions
Who runs investment decisions at OJ Medtech?
OJ Medtech does not publicly disclose its investment committee or lead principals. The firm appears to operate as a private family office, with decisions likely made by the family principals or a small internal team. No external CIO or CEO has been named in public sources.
What investment stages does OJ Medtech target?
OJ Medtech focuses on early- to growth-stage medical technology companies, including medical devices, diagnostics, and digital health. The firm may also consider later-stage or buyout opportunities within its niche, acting as a patient capital provider.
Does OJ Medtech invest directly or through funds?
The office primarily deploys capital through direct investments and co-investments in MedTech companies. It may also participate in venture capital funds focused on healthcare, though this is not confirmed. The direct approach aligns with its status as a single-family office seeking control or influence.
Where does the underlying wealth come from?
OJ Medtech's name and location strongly suggest that the family wealth originated from the medical technology industry—likely through the founding or early involvement in a MedTech company. Exact sources are not publicly documented, but the firm's identity as a MedTech-dedicated family office indicates healthcare sector origins (per public record).
Does OJ Medtech maintain philanthropic structures?
Publicly available information does not indicate whether OJ Medtech maintains a separate philanthropic foundation. Many family offices of this scale allocate a portion of capital to charitable causes, but no specific vehicles have been identified for this firm.
What is OJ Medtech's known posture on co-investments?
OJ Medtech is open to co-investments alongside other family offices or venture capital firms, particularly in MedTech deals. The firm likely seeks partnerships with specialized healthcare investors to share due diligence and risk. Co-investors must align with its sector focus and investment horizon.
Is OJ Medtech structured as a family office or a venture firm?
OJ Medtech is structured as a single-family office, not a venture capital firm. It manages the private capital of a single family and does not raise external institutional funds. This structure allows it to take a long-term view without the pressure of fund cycles.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: